Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanome develops AI-powered digital health solutions integrating multimodal biomarker data to enable earlier disease detection and risk prediction. Their core technology—an AI-driven Human Digital Twin—translates diverse patient data into actionable clinical insights. The company’s first product suite includes MEMORI (clinical decision support tool) and CENTAURI (data analytics platform), both designed to improve patient outcomes by supporting earlier interventions. As of mid–2025, their main products are in the process of regulatory validation with no published clinical trial results yet.[1][2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanome.